19
Sep
The U.S. Court of Appeals for the Fifth Circuit will hear oral arguments in Louisiana v. U.S. Food and Drug Administration (FDA), a lawsuit seeking to end mail and pharmacy access to mifepristone nationwide—including in states where abortion is protected.
